TotalMarketCap

Praxis Precision Medicines

PRAXNasdaq United StatesHealth CareBiotechnology: Pharmaceutical Preparations

Market cap

$7.917 B

$283.56 -4.04%

Close of 6 Oct 2026

As of 6 Oct 2026, Praxis Precision Medicines (PRAX) has a market capitalization of $7.92B. Market cap measures the value of outstanding equity at market prices; company totals combine applicable share classes. Prices and market caps come from Nasdaq, with financial fundamentals from SEC filings. See sources and calculation details.

Revenue

$0.00

#3634 by revenue

Earnings

-$303.0M

Loss-making

Shares outstanding

27,919,988

Latest filing cover page

P/E ratio

—

Cap ÷ net income

Biotechnology: Pharmaceutical Preparations, ranked by market cap

All 500 →
  1. #39Spyre TherapeuticsSYRE$8.18B
  2. #40AbivaxABVX$8.00B
  3. #41Praxis Precision MedicinesPRAX$7.92B
  4. #42Ionis PharmaceuticalsIONS$7.23B
  5. #43AlkermesALKS$7.17B

What if Praxis Precision Medicines were worth as much as…

Open the what-if tool →

Gold $28.8T

$1,032,626

Per share 3,642× higher

Bitcoin $1.68T

$60,283.11

Per share 213× higher

Nvidia $5.76T

$206,213.91

Per share 727× higher

Or at a round number

$10.0B$20.0B$50.0B$100.0B

Where these numbers come from

Share counts and financials for Praxis Precision Medicines are taken from its own SEC filings via EDGAR: public record, not an estimate. Market cap is shares outstanding multiplied by the latest close. Last updated 7 Oct 2026. Read the methodology.